Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Venous thromboembolism and transfusion after major abdominopelvic surgery.

McAlpine K, Breau RH, Knee C, Carrier M, Violette PD, van Walraven C, McIsaac DI, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Surgery. 2019 Jul 31. pii: S0039-6060(19)30337-X. doi: 10.1016/j.surg.2019.05.050. [Epub ahead of print]

PMID:
31377000
2.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.

3.

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH.

J Urol. 2019 May 17:101097JU0000000000000341. doi: 10.1097/JU.0000000000000341. [Epub ahead of print]

PMID:
31099720
4.

Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol.

Breau RH, Cagiannos I, Knoll G, Morash C, Cnossen S, Lavallée LT, Mallick R, Finelli A, Jewett M, Leibovich BC, Cook J, LeBel L, Kapoor A, Pouliot F, Izawa J, Rendon R, Fergusson DA.

BMJ Open. 2019 Jan 3;9(1):e025662. doi: 10.1136/bmjopen-2018-025662.

5.

Standardized reporting templates with mandatory reporting fields and "pick-list" options improve use of Prostate Imaging and Data Reporting System version 2 in clinical practice: A plan-do-study-act analysis.

Moran K, Breau RH, Cagiannos I, Lavallée LT, Morash C, O'Sullivan J, Schieda N.

Can Urol Assoc J. 2019 Jun;13(6):212-214. doi: 10.5489/cuaj.5630. No abstract available.

6.

Robotic surgery improves transfusion rate and perioperative outcomes using a broad implementation process and multiple surgeon learning curves.

McAlpine K, Forster AJ, Breau RH, McIsaac D, Tufts J, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2019 Jun;13(6):184-189. doi: 10.5489/cuaj.5527.

7.

The effect of surgery report cards on improving radical prostatectomy quality: the SuRep study protocol.

Breau RH, Kumar RM, Lavallee LT, Cagiannos I, Morash C, Horrigan M, Cnossen S, Mallick R, Stacey D, Fung-Kee-Fung M, Morash R, Smylie J, Witiuk K, Fergusson DA.

BMC Urol. 2018 Oct 19;18(1):89. doi: 10.1186/s12894-018-0403-y.

8.

Female radical cystectomy patients have a higher risk of surgical site infections.

Abdi H, Elzayat E, Cagiannos I, Lavallée LT, Cnossen S, Flaman AS, Mallick R, Morash C, Breau RH.

Urol Oncol. 2018 Sep;36(9):400.e1-400.e5. doi: 10.1016/j.urolonc.2018.05.023. Epub 2018 Jul 29.

PMID:
30064934
9.

Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.

Mcalpine K, Fergusson DA, Breau RH, Reynolds LF, Shorr R, Morgan SC, Eapen L, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2018 Oct;12(10):351-360. doi: 10.5489/cuaj.5244. Epub 2018 May 28. Review.

10.

Multiparametric magnetic resonance imaging - Transrectal ultrasound-guided cognitive fusion biopsy of the prostate: Clinically significant cancer detection rates stratified by the Prostate Imaging and Data Reporting System version 2 assessment category.

John S, Cooper S, Breau RH, Flood TA, Cagiannos I, Lavallee LT, Morash C, O'sullivan J, Schieda N.

Can Urol Assoc J. 2018 Jun 19. doi: 10.5489/cuaj.5254. [Epub ahead of print]

11.

Reducing overtreatment of prostate cancer by radical prostatectomy in Eastern Ontario: a population-based cohort study.

Witherspoon L, Lau JL, Breau RH, Knee C, Fung MFK, Morash R, Mallick R, Cagiannos I, Morash C, Lavallée LT.

CMAJ Open. 2018 Apr 30;6(2):E197-E201. doi: 10.9778/cmajo.20170149.

12.

Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.

Breau RH, Lavallée LT, Cnossen S, Witiuk K, Cagiannos I, Momoli F, Bryson G, Kanji S, Morash C, Turgeon A, Zarychanski R, Mallick R, Knoll G, Fergusson DA.

Trials. 2018 May 2;19(1):261. doi: 10.1186/s13063-018-2626-3.

13.

Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma.

Locke JA, Hamidizadeh R, Kassouf W, Rendon RA, Bell D, Izawa J, Chin J, Kapoor A, Shayegen B, Lattouf JB, Saad F, Lacombe L, Fradet Y, Fairey AS, Jacobson NE, Drachenberg DE, Cagiannos I, So AI, Black PC.

Can Urol Assoc J. 2018 Aug;12(8):243-251. doi: 10.5489/cuaj.5377. Epub 2018 Apr 12.

14.

Age-stratified perioperative mortality after urological surgeries.

Wallace B, Breau RH, Cnossen S, Knee C, Mcisaac D, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2018 Aug;12(8):256-259. doi: 10.5489/cuaj.5022. Epub 2018 Apr 6.

15.

Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.

Nayak AL, Cagiannos I, Lavallée LT, Morash C, Hickling D, Mallick R, Breau RH.

Can Urol Assoc J. 2018 Jun;12(6):181-186. doi: 10.5489/cuaj.4877. Epub 2018 Feb 23.

16.

Long-term patient outcomes from the first year of a robotic surgery program using multi-surgeon implementation.

Montroy J, Elzayat E, Morash C, Blew B, Lavallée LT, Cagiannos I, Watterson J, Oake JS, Fungkeefung M, Thompson C, Weber R, Breau RH.

Can Urol Assoc J. 2018 Feb;12(2):38-43. doi: 10.5489/cuaj.4528. Epub 2017 Dec 1.

17.

An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients.

da Silva V, Cagiannos I, Lavallée LT, Mallick R, Witiuk K, Cnossen S, Eastham JA, Fergusson DA, Morash C, Breau RH.

Can Urol Assoc J. 2017 Aug;11(8):238-243. doi: 10.5489/cuaj.4093.

18.

Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).

Lavallée LT, Fitzpatrick R, Wood LA, Basiuk J, Knee C, Cnossen S, Mallick R, Witiuk K, Vanhuyse M, Tanguay S, Finelli A, Jewett MAS, Basappa N, Lattouf JB, Gotto GT, Al-Asaaed S, Bjarnason GA, Moore R, North S, Canil C, Pouliot F, Soulières D, Castonguay V, Kassouf W, Cagiannos I, Morash C, Breau RH.

J Cancer Educ. 2019 Feb;34(1):14-18. doi: 10.1007/s13187-017-1259-7.

PMID:
28779441
19.

Are renal tumour scoring systems better than clinical judgement at predicting partial nephrectomy complexity?

Kumar RM, Lavallée LT, Desantis D, Cnossen S, Mallick R, Cagiannos I, Morash C, Breau RH.

Can Urol Assoc J. 2017 Jun;11(6):199-203. doi: 10.5489/cuaj.4228.

20.

The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis.

Montroy J, Fergusson NA, Hutton B, Lavallée LT, Morash C, Cagiannos I, Cnossen S, Fergusson DA, Breau RH.

Transfus Med Rev. 2017 Jul;31(3):141-148. doi: 10.1016/j.tmrv.2017.03.002. Epub 2017 Mar 22. Review.

PMID:
28366637
21.

The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Nguyen LN, Head L, Witiuk K, Punjani N, Mallick R, Cnossen S, Fergusson DA, Cagiannos I, Lavallée LT, Morash C, Breau RH.

J Urol. 2017 Oct;198(4):760-769. doi: 10.1016/j.juro.2017.02.3344. Epub 2017 Mar 9.

PMID:
28286069
22.

Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology.

McAlpine K, Breau RH, Mallick R, Cnossen S, Cagiannos I, Morash C, Carrier M, Lavallée LT.

Urol Oncol. 2017 Jul;35(7):457.e1-457.e8. doi: 10.1016/j.urolonc.2017.01.015. Epub 2017 Feb 15.

PMID:
28214280
23.

Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.

Chung AD, Schieda N, Flood TA, Cagiannos I, Mai KT, Malone S, Morash C, Hakim SW, Breau RH.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E50-E57. doi: 10.5489/cuaj.3789. Epub 2017 Jan 12.

24.

Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens.

Paterson NR, Lavallée LT, Nguyen LN, Witiuk K, Ross J, Mallick R, Shabana W, MacDonald B, Scheida N, Fergusson D, Momoli F, Cnossen S, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2016 Aug;10(7-8):264-268.

25.

Current prostate cancer treatment: Not what but when?

Massaro PA, Cagiannos I.

Can Urol Assoc J. 2016 Aug;10(7-8):251-252. No abstract available.

26.

Laparoscopic nephroureterectomy is associated with higher risk of adverse events compared to laparoscopic radical nephrectomy.

Bastiampillai R, Lavallée LT, Cnossen S, Witiuk K, Mallick R, Fergusson D, Schramm D, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2016 Mar-Apr;10(3-4):126-31. doi: 10.5489/cuaj.3362.

27.

The effect of wide resection during radical prostatectomy on surgical margins.

Lavallée LT, Stokl A, Cnossen S, Mallick R, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):14-7. doi: 10.5489/cuaj.3326.

28.

Active surveillance in Canadian men with low-grade prostate cancer.

Cristea O, Lavallée LT, Montroy J, Stokl A, Cnossen S, Mallick R, Fergusson D, Momoli F, Cagiannos I, Morash C, Breau RH.

CMAJ. 2016 May 17;188(8):E141-E147. doi: 10.1503/cmaj.150832. Epub 2016 Feb 29.

29.

Multiparametric MRI of the anterior prostate gland: clinical-radiological-histopathological correlation.

Moosavi B, Flood TA, Al-Dandan O, Breau RH, Cagiannos I, Morash C, Malone SC, Schieda N.

Clin Radiol. 2016 May;71(5):405-17. doi: 10.1016/j.crad.2016.01.002. Epub 2016 Feb 14. Review.

PMID:
26888762
30.

Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing.

Lavallée LT, Binette A, Witiuk K, Cnossen S, Mallick R, Fergusson DA, Momoli F, Morash C, Cagiannos I, Breau RH.

Mayo Clin Proc. 2016 Jan;91(1):17-22. doi: 10.1016/j.mayocp.2015.07.030. Epub 2015 Dec 10.

PMID:
26688045
31.

Canadian guidelines for the management of small renal masses (SRM).

Jewett MA, Rendon R, Lacombe L, Karakiewicz PI, Tanguay S, Kassouf W, Leveridge M, Cagiannos I, Kapoor A, Pautler S, Drachtenberg D, Moore R, Gleave M, Evans A, Haider M, Finelli A.

Can Urol Assoc J. 2015 May-Jun;9(5-6):160-3. doi: 10.5489/cuaj.2969. No abstract available.

32.

Surgical management of stage T1 renal tumours at Canadian academic centres.

Lavallée LT, Tanguay S, Jewett MA, Wood L, Kapoor A, Rendon RA, Moore RB, Lacombe L, Kawakami J, Pautler SE, Drachenberg DE, Black PC, Lattouf JB, Morash C, Cagiannos I, Liu Z, Breau RH.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):99-106. doi: 10.5489/cuaj.2598. Erratum in: Can Urol Assoc J. 2016 Aug;10 (7-8):E281.

33.

Suburothelial and extrinsic lesions of the urinary bladder: radiologic and pathologic features with emphasis on MR imaging.

Chung AD, Schieda N, Flood TA, Cagiannos I, Kielar AZ, McInnes MD, Siegelman ES.

Abdom Imaging. 2015 Oct;40(7):2573-88. doi: 10.1007/s00261-015-0467-z. Review.

PMID:
26048699
34.

The association between renal tumour scoring system components and complications of partial nephrectomy.

Desantis D, Lavallée LT, Witiuk K, Mallick R, Kamal F, Fergusson D, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2015 Jan-Feb;9(1-2):39-45. doi: 10.5489/cuaj.2303.

35.

The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence.

Kapoor A, Dason S, Allard CB, Shayegan B, Lacombe L, Rendon R, Jacobsen NE, Fairey A, Izawa J, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Drachenberg D, Cagiannos I, Fradet Y, Alamri A, Kassouf W.

Can Urol Assoc J. 2014 Nov;8(11-12):E845-52. doi: 10.5489/cuaj.1985.

36.

Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals.

Lavallée LT, Schramm D, Witiuk K, Mallick R, Fergusson D, Morash C, Cagiannos I, Breau RH.

PLoS One. 2014 Oct 31;9(10):e111281. doi: 10.1371/journal.pone.0111281. eCollection 2014.

37.

The association between nerve sparing and a positive surgical margin during radical prostatectomy.

Preston MA, Breau RH, Lantz AG, Morash C, Gerridzen RG, Doucette S, Mallick R, Eastham JA, Cagiannos I.

Urol Oncol. 2015 Jan;33(1):18.e1-18.e6. doi: 10.1016/j.urolonc.2014.09.006. Epub 2014 Oct 11.

PMID:
25308562
38.

Predicting the Gleason sum of a patient with a prostate biopsy core Gleason ≤7 and a prostate biopsy core Gleason ≥8.

Heimrath OP, Kos Z, Belanger EC, Cagiannos I, Morash C, Gerridzen RG, Lavallée LT, Preston MA, Witiuk K, Breau RH.

Can Urol Assoc J. 2014 Jul;8(7-8):E476-80. doi: 10.5489/cuaj.1737.

39.

The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis.

Breau RH, Kokolo MB, Punjani N, Cagiannos I, Beck A, Niznick N, Buenaventura C, Cowan J, Knoll G, Momoli F, Morash C, Ruzicka M, Schachkina S, Tinmouth A, Xie HY, Fergusson DA.

Transfus Med Rev. 2014 Jul;28(3):145-55. doi: 10.1016/j.tmrv.2014.05.002. Epub 2014 May 18. Review.

PMID:
24958068
40.

Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.

Fradet V, Mauermann J, Kassouf W, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Sheyegan B, Drachenberg D, Cagiannos I, Lacombe L.

Urol Oncol. 2014 Aug;32(6):839-45. doi: 10.1016/j.urolonc.2014.04.006. Epub 2014 May 22.

PMID:
24856978
41.

Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaboration.

Bachir BG, Aprikian AG, Izawa JI, Chin JL, Fradet Y, Fairey A, Estey E, Jacobsen N, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Kapoor A, Matsumoto E, Saad F, Bell D, Black PC, So AI, Drachenberg D, Kassouf W.

Urol Oncol. 2014 May;32(4):441-8. doi: 10.1016/j.urolonc.2013.10.016. Epub 2014 Jan 10.

PMID:
24412632
42.

Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system.

Bachir BG, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E667-72. doi: 10.5489/cuaj.201.

43.

Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.

Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk K, Morash C, Cagiannos I, Breau RH.

PLoS One. 2013 Nov 4;8(11):e79773. doi: 10.1371/journal.pone.0079773. eCollection 2013.

44.

Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.

Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Saad F, Bell D, Drachenberg D, Kassouf W.

World J Urol. 2014 Oct;32(5):1295-301. doi: 10.1007/s00345-013-1207-z. Epub 2013 Nov 10.

PMID:
24213922
45.

CyberKnife for inoperable renal tumors: Canadian pioneering experience.

Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Breau R, Malone C, Avruch L, Pantarotto J, Malone S.

Can J Urol. 2013 Oct;20(5):6944-9. Review.

PMID:
24128835
46.

Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis.

Breau RH, Karnes RJ, Farmer SA, Thapa P, Cagiannos I, Morash C, Frank I.

BJU Int. 2014 Jun;113(6):900-6. doi: 10.1111/bju.12403. Epub 2013 Nov 27.

47.

Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma.

Wood L, Bjarnason GA, Black PC, Cagiannos I, Heng DY, Kapoor A, Kollmannsberger CK, Mohammadzadeh F, Moore RB, Rendon RA, Soulieres D, Tanguay S, Venner P, Jewett M, Finelli A.

J Oncol Pract. 2013 Sep;9(5):e262-7. doi: 10.1200/JOP.2012.000870. Epub 2013 Jun 4.

PMID:
23943895
48.

Comorbidity status does not independently predict survival outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Fairey AS, Jacobsen NE, Estey E, Tanguay S, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Black P, So A, Lattouf JB, Saad F, Drachenberg D, Cagiannos I, Lacombe L, Fradet Y, Kassouf W.

Eur Urol. 2013 Sep;64(3):518-9. doi: 10.1016/j.eururo.2013.06.014. Epub 2013 Jun 19. No abstract available.

PMID:
23796500
49.

Blood transfusion and hemostatic agents used during radical cystectomy.

Punjani N, Lavallée LT, Momoli F, Fergusson D, Witiuk K, Mallick R, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2013 May-Jun;7(5-6):E275-80. doi: 10.5489/cuaj.1002.

50.

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Moretto P, Wood L, Emmenegger U, Blais N, Mukherjee SD, Winquist E, Belanger EC, Macrae R, Balogh A, Cagiannos I, Kassouf W, Black P, Czaykowski P, Gingerich J, North S, Ernst S, Richter S, Sridhar S, Reaume MN, Soulieres D, Eisen A, Canil CM.

Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E44-56. doi: 10.5489/cuaj.220. No abstract available.

Supplemental Content

Loading ...
Support Center